CervoMed (CRVO) News Today $9.77 +0.09 (+0.93%) Closing price 04:00 PM EasternExtended Trading$9.69 -0.08 (-0.82%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Comparing Sensei Biotherapeutics (NASDAQ:SNSE) & CervoMed (NASDAQ:CRVO)April 15 at 1:15 AM | americanbankingnews.comFinancial Analysis: CervoMed (NASDAQ:CRVO) vs. MusclePharm (OTCMKTS:MSLP)April 12 at 2:05 AM | americanbankingnews.comCervoMed to present results on Phase 2b RewinD-LB studyApril 3, 2025 | markets.businessinsider.comCervoMed (CRVO) Expected to Announce Quarterly Earnings on FridayCervoMed (NASDAQ:CRVO) will be releasing earnings before the market opens on Friday, April 4, Financial Modeling Prep reports.April 3, 2025 | marketbeat.comCervoMed Inc. (NASDAQ:CRVO) Given Average Recommendation of "Moderate Buy" by AnalystsShares of CervoMed Inc. (NASDAQ:CRVO - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the nine research firms that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold ratiApril 2, 2025 | marketbeat.comCervoMed Inc. (NASDAQ:CRVO) Short Interest UpdateCervoMed Inc. (NASDAQ:CRVO - Get Free Report) saw a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 2,630,000 shares, a growth of 190.7% from the February 28th total of 904,700 shares. Currently, 46.6% of the company's shares are short sold. Based on an average daily trading volume, of 4,280,000 shares, the short-interest ratio is presently 0.6 days.March 28, 2025 | marketbeat.comFY2025 EPS Estimate for CervoMed Decreased by AnalystCervoMed Inc. (NASDAQ:CRVO - Free Report) - Stock analysts at Chardan Capital cut their FY2025 earnings estimates for shares of CervoMed in a research note issued to investors on Monday, March 24th. Chardan Capital analyst D. Gataulin now expects that the company will earn ($2.68) per share for tMarch 28, 2025 | marketbeat.comCervoMed (CRVO) Projected to Post Quarterly Earnings on FridayCervoMed (NASDAQ:CRVO) will be releasing earnings before the market opens on Friday, April 4, Financial Modeling Prep reports.March 28, 2025 | marketbeat.comCervoMed (NASDAQ:CRVO) Given Buy Rating at D. Boral CapitalD. Boral Capital restated a "buy" rating and issued a $10.00 price target on shares of CervoMed in a report on Wednesday.March 27, 2025 | marketbeat.comCervoMed Announces Oral Presentation at 19th International Conference on Alzheimer's and Parkinson's Diseases and Related Neurologic Disorders (AP/PD™)March 25, 2025 | globenewswire.comCervoMed Inc trading resumesMarch 21, 2025 | markets.businessinsider.comCervoMed Inc trading halted, volatility trading pauseMarch 21, 2025 | markets.businessinsider.comCervoMed Q1 EPS Increased by Brookline Capital ManagementCervoMed Inc. (NASDAQ:CRVO - Free Report) - Stock analysts at Brookline Capital Management upped their Q1 2025 EPS estimates for CervoMed in a research report issued to clients and investors on Tuesday, March 18th. Brookline Capital Management analyst T. Bussian now anticipates that the company wMarch 21, 2025 | marketbeat.comRoth Capital Issues Negative Outlook for CervoMed EarningsCervoMed Inc. (NASDAQ:CRVO - Free Report) - Investment analysts at Roth Capital dropped their Q1 2025 earnings per share (EPS) estimates for shares of CervoMed in a report issued on Tuesday, March 18th. Roth Capital analyst B. Pachaiyappan now expects that the company will post earnings of ($0.80March 21, 2025 | marketbeat.comEquities Analysts Set Expectations for CervoMed Q1 EarningsCervoMed Inc. (NASDAQ:CRVO - Free Report) - Research analysts at Roth Capital issued their Q1 2026 earnings per share (EPS) estimates for CervoMed in a report issued on Tuesday, March 18th. Roth Capital analyst B. Pachaiyappan forecasts that the company will post earnings of ($0.52) per share forMarch 20, 2025 | marketbeat.com3CRVO : Peering Into CervoMed's Recent Short InterestMarch 19, 2025 | benzinga.comIs CervoMed Inc. (CRVO) Among the Best Short Squeeze Stocks to Buy According to Analysts?March 19, 2025 | msn.comCervoMed (NASDAQ:CRVO) Price Target Raised to $20.00Roth Mkm lifted their price target on CervoMed from $15.00 to $20.00 and gave the stock a "buy" rating in a research note on Tuesday.March 19, 2025 | marketbeat.comCervoMed (NASDAQ:CRVO) Price Target Raised to $21.00 at Canaccord Genuity GroupCanaccord Genuity Group upped their price objective on shares of CervoMed from $12.00 to $21.00 and gave the company a "buy" rating in a report on Tuesday.March 19, 2025 | marketbeat.comChardan Capital upgrades CervoMed (CRVO) to a BuyMarch 18, 2025 | markets.businessinsider.comCervoMed price target raised to $20 from $15 at Roth MKMMarch 18, 2025 | markets.businessinsider.comCervoMed price target raised to $21 from $12 at CanaccordMarch 18, 2025 | markets.businessinsider.comCervoMed Inc. (CRVO): The Best Short-Term Stock to Buy Right NowMarch 18, 2025 | msn.comCervoMed (NASDAQ:CRVO) Receives "Buy" Rating from D. Boral CapitalD. Boral Capital reiterated a "buy" rating and issued a $10.00 price objective on shares of CervoMed in a research note on Monday.March 18, 2025 | marketbeat.comCervoMed (NASDAQ:CRVO) Issues Earnings ResultsCervoMed (NASDAQ:CRVO - Get Free Report) announced its earnings results on Monday. The company reported ($0.80) earnings per share for the quarter, missing analysts' consensus estimates of ($0.67) by ($0.13). CervoMed had a negative return on equity of 44.11% and a negative net margin of 118.68%.March 18, 2025 | marketbeat.comCervoMed reports FY24 EPS ($2.02), consensus ($1.85)March 17, 2025 | markets.businessinsider.comCervoMed Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate UpdatesMarch 17, 2025 | markets.businessinsider.comCervoMed sees cash runway into mid-2026March 17, 2025 | markets.businessinsider.comWe Think CervoMed (NASDAQ:CRVO) Can Afford To Drive Business GrowthMarch 14, 2025 | uk.finance.yahoo.comJones Trading Upgrades CervoMed (CRVO)March 14, 2025 | msn.comCervoMed upgraded to Buy from Hold at JonesResearchMarch 13, 2025 | markets.businessinsider.comCervoMed upgraded to Buy at JonesResearch on more confidence in DLB programMarch 13, 2025 | markets.businessinsider.comChardan Capital Upgrades CervoMed (CRVO)March 13, 2025 | msn.comCervoMed upgraded to Buy from Neutral at ChardanMarch 13, 2025 | markets.businessinsider.comCervoMed price target raised to $15 from $7 at Roth MKMMarch 11, 2025 | markets.businessinsider.comJonesTrading Sticks to Its Hold Rating for CervoMed (CRVO)March 11, 2025 | markets.businessinsider.comCervoMed announces results from extension phase of RewinD-LB studyMarch 10, 2025 | markets.businessinsider.comCervoMed Announces Positive Results from the Extension Phase of its Phase 2b Clinical Study of Neflamapimod in Patients with Dementia with Lewy BodiesMarch 10, 2025 | globenewswire.comCervoMed upgraded to Buy from Hold at D. Boral CapitalFebruary 20, 2025 | markets.businessinsider.comD. Boral Capital Upgrades CervoMed (CRVO)February 19, 2025 | msn.comCervoMed Provides Update on Neflamapimod DLB Program as Part of Presentation at the 8th International Lewy Body Dementia ConferenceJanuary 31, 2025 | finance.yahoo.comCervoMed provides update on neflamapimod DLB programJanuary 31, 2025 | markets.businessinsider.comCervoMed to Present at the 8th International Lewy Body Dementia ConferenceJanuary 29, 2025 | globenewswire.comCervoMed downgraded to Neutral from Buy at H.C. WainwrightDecember 17, 2024 | markets.businessinsider.comHC Wainwright & Co. Downgrades CervoMed (CRVO)December 17, 2024 | msn.comCervoMed (CRVO) was downgraded to a Hold Rating at H.C. WainwrightDecember 17, 2024 | markets.businessinsider.comCervoMed announces inducement grants under Nasdaq lisitng ruleDecember 13, 2024 | markets.businessinsider.comCervoMed Inc.: CervoMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)December 12, 2024 | finanznachrichten.deCervoMed price target lowered to $12 from $65 at CanaccordDecember 12, 2024 | markets.businessinsider.comCervoMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)December 12, 2024 | globenewswire.com Remove Ads Get CervoMed News Delivered to You Automatically Sign up to receive the latest news and ratings for CRVO and its competitors with MarketBeat's FREE daily newsletter. Email Address CRVO Media Mentions By Week CRVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRVO News Sentiment▼0.720.78▲Average Medical News Sentiment CRVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRVO Articles This Week▼42▲CRVO Articles Average Week Remove Ads Get CervoMed News Delivered to You Automatically Sign up to receive the latest news and ratings for CRVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PHAT News KMDA News ABVX News ORIC News STOK News TRML News ETON News ALLO News TRDA News AMLX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRVO) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CervoMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CervoMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CRVO Stock Free CRVO Stock Alerts